Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NKAEs in Relapsed/Refractory Paediatric T-ALL/T-LBL
NCT01944982Phase 2Terminated
- Sponsor
- Hospital Universitario Niño Jesús
- Start
- Jul 2013
- Primary completion
- Sep 2016
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of expanded haploidentical NK cells in t-cell acute lymphoblastic leukemia (T-ALL) and T cell lymphoblastic lymphoma (T-LBL), sponsored by Hospital Universitario Niño Jesús. Primary endpoint: Safety profile (number of AEs per patient) at 2 months. Started Jul 2013; status: terminated.
02
Drugs
expanded haploidentical NK cells
03
Conditions
t-cell acute lymphoblastic leukemia (T-ALL)T cell lymphoblastic lymphoma (T-LBL)
Beyond the preview
Go deeper on NCT01944982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01944982.